Pharmaceutical Business review

Nucletron Reports Net Sales Of $165 Million For Year-End 2008

Among the several advancements announced in 2008 was the introduction on Oncentra Brachy, a new volume-based treatment planning solution that optimizes cancer treatment planning with brachytherapy. Additionally, Oncentra RT Viewer received clearance in 2008. Oncentra RT Viewer enables clinicians to review radiotherapy plans generated with a wide variety of DICOM-compliant treatment planning systems in a Windows (PC) environment.

“In the second half of 2008, we improved our focus on innovation and marketing efforts, while strengthening our management team. Given our many upcoming product releases in the months to come, we are on track to achieve our 2009 goals as planned,” said Jos Lamers, chief executive officer of Nucletron.

Exit mobile version